| payload |
{"created_at":"2026-04-15T13:04:55.082 {"created_at":"2026-04-15T13:04:55.082124+00:00","signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","url":"https://www.nasdaq.com/articles/prelude-therapeutics-appoints-charles-morris-chief-medical-officer","value":{"fp":"89889838fda3132f","kind":"unusual_volume","published_at":"2026-04-15T12:02:47+00:00","source":"Nasdaq Markets","summary":"(RTTNews) - Prelude Therapeutics Incorporated (PRLD), a clinical-stage precision oncology company, said on Wednesday that Charles Morris will join the company as chief medical officer with effect from April 20.","tickers":["PRLD"],"title":"Prelude Therapeutics Appoints Charles Morris As Chief Medical Officer","url":"https://www.nasdaq.com/articles/prelude-therapeutics-appoints-charles-morris-chief-medical-officer"}}... |